ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCully, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCully, K.
Annals of Clinical and Laboratory Science, Vol 24, Issue 2, 134-152
Copyright © 1994 by Association of Clinical Scientists

Articles

Chemical pathology of homocysteine. III. Cellular function and aging

KS McCully

The homocysteine thiolactonyl derivative, thioretinaco ozonide, is believed to function as an electron acceptor in oxygen metabolism and as the binding site for adenosine triphosphate (ATP) synthesis by mitochondria, preventing damage by free radical oxidants in resting cells. During cell division, methionine is converted to homocysteine thiolactone, converting thioretinaco to thioco, increasing free radical oxidants, and oxidizing cellular glutathione and ascorbate. Homocysteic acid has growth hormone activity and releases insulin-like growth factor in hypophysectomized rats, promoting oxidation of homocysteine thiolactone to sulfated glycosaminoglycans of cartilage. The free base of homocysteine thiolactone produces keratinization, squamous metaplasia, dysplasia, and carcinogenesis in normal mouse tissues. The efficiency of homocysteine thiolactone metabolism declines with aging, explaining decreased formation of adenosyl methionine in aging and suggesting loss of thioretinaco ozonide from membranes of aging cells. The effects of aging on enzyme activity, connective tissues, lipid synthesis, auto-immune diseases, atherogenesis and carcinogenesis are related to these changes in homocysteine metabolism.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
N. Li, F.-X. Yi, E. Rute, D. X. Zhang, G. R. Slocum, and A.-P. Zou
Effects of homocysteine on intracellular nitric oxide and superoxide levels in the renal arterial endothelium
Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1237 - H1243.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
G. N. Welch and J. Loscalzo
Homocysteine and Atherothrombosis
N. Engl. J. Med., April 9, 1998; 338(15): 1042 - 1050.
[Full Text] [PDF]

Home page
 JAMAHome page
K. S. McCully
Homocysteine, Folate, Vitamin B6, and Cardiovascular Disease
JAMA, February 4, 1998; 279(5): 392 - 393.
[Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
A. Majors, L. A. Ehrhart, and E. H. Pezacka
Homocysteine as a Risk Factor for Vascular Disease : Enhanced Collagen Production and Accumulation by Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 2074 - 2081.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the Association of Clinical Scientists.